SEC Tracker
Get the app

Retension Pharmaceuticals RTSN

Retension Pharmaceuticals goes public

Securities offering

Form
424B4
Filed
Importance
Routine
  1. 3,750,000 shares offered
  2. IPO price of $12.00 per share
  3. Listed on Nasdaq under RTSN
  4. Proceeds to company: $41.85M

Written from the 424B4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Retension Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX